This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Natalie Boytsov, PhD
Advertisement
Articles by Natalie Boytsov, PhD
We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Advertisement
Latest Updated Articles
- Daily Dose and Costs of Therapy With Topical Testosterone Agents
December 16th 2014
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
3
Patient-Reported Outcomes, Machine Learning May Predict Breast Cancer Recurrence Earlier
4
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
5